Velosity Capital

Endeavor BioMedicines develops new treatments targeting the underlying causes of pulmonary fibrosis.

Diagonal Therapeutics is a biotechnology startup that is pioneering a novel technique to finding and producing agonist antibodies.

Sudo Biosciences is a biopharma company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain.

Sudo Biosciences is a biopharma company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain.

Sudo Biosciences is a biopharma company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain.

Koneksa Health is a healthcare data analytics company that helps researchers incorporate emerging technologies into their clinical studies.

Wugen is developing off-the-shelf cellular therapies targeting solid tumors and hematologic malignancies

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.